SAN DIEGO (Legal Newsline) – A cancer patient has filed a class action lawsuit over the alleged ineffectiveness of stem cell therapy.
Christina Mendez filed her case on May 15 in San Diego federal court against the Global Institute of Stem Cell Therapy and Research, also known as Giostar.
Mendez says she was 29 when diagnosed with Stage II Hodgkin lymphoma and was symptom-free for a year when she sought treatment by the defendant.
She was given stem cell therapy without first undergoing chemotherapy or radiation, and the institute failed to match the cells injected into her body with her own cells, causing rejection, the lawsuit says.
After spending tens of thousands of dollars, her cancer went from Stage II to State IV and her liver began to fail, the lawsuit says. She was told she had a year to live, at the most.
Surgery, transfusions and eight months of chemo sent her into remission, she says.
The complaint takes issue with a quote by Mahatma Gandhi on the institute’s home page.
“In a twisted juxtaposition, Defendants have used Gandhi – a cultural and religious icon – and a quote about truth-saying, to peddle their misrepresentations and lies,” the complaint says.
“While Gandhi sought truth and change through nonviolent means, the false statements and material omissions made by Defendants have dire and sometimes fatal consequences.”
The lawsuit alleges the institute misrepresents that its stem cell treatment can treat and cure “blood-related diseases” like sickle cell anemia, leukemia, lymphoma and thalassemia.
U.S. District Court for the Southern District of California case number 3:20-cv-00915